Toronto - Toronto Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||N/A|
- Associated Press•last year
One of the companies that had been studying a potential treatment for the Ebola virus said Monday it will suspend its research on Ebola drugs and change its name. Tekmira Pharmaceuticals Corp. said last ...
- Investor's Business Daily•last year
The new class of hepatitis C drugs, led by Gilead Sciences (GILD) and AbbVie (ABBV), has turned into one of the biggest success stories in biotech history. Yet hepatitis C is one of only five viruses that ...